Company Monitoring Page for Novartis

latest headlines for company on cafepharma

"Breakthrough Therapy" Status Could Hasten Novartis Drug Review
Motley Fool
Wed, 08/21/13 - 09:05 am
Tags:
Novartis, breakthrough therapies, BYM338, sporadic inclusion body myositis, FDA
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
Tags:
JNJ, Novartis, Pfizer, Merck, Roche, Bayer, Sanofi, GSK, Abbott Labs, AstraZeneca, Eli Lilly
Avanir, Sandoz settle Nuedexta patent litigation
Pharmaceutical Business Review
Fri, 08/16/13 - 10:55 am
Tags:
Avanir, Sanzoz, patents, generics, Novartis, Nuedexta
2 Biotech Stocks That Could Be on Novartis' Buyout Radar
Motley Fool
Thu, 08/15/13 - 11:48 am
Tags:
Novartis, M&A, Biomarin, Incyte
Novartis to Review Business as Reinhardt Becomes Chairman, Would Consider a $10 Billion Purchase
Bloomberg
Wed, 08/14/13 - 10:21 am
Tags:
Novartis, Joerg Reinhardt, M&A
Novartis, Pfizer Said to Be Out of Bidding for Onyx
Bloomberg
Wed, 08/14/13 - 10:19 am
Tags:
Novartis, Pfizer, ONYX Pharmaceuticals, Amgen, M&A
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wed, 08/14/13 - 10:16 am
Tags:
Receptos, Novartis, Gilenya, MS, multiple sclerosis, RPC1063
China to launch fresh pharmaceutical bribery probe
Yahoo/Reuters
Wed, 08/14/13 - 09:32 am
Tags:
China, Novartis
Report: Novartis Bails on Onyx Bid
Barron's
Tue, 08/13/13 - 04:06 pm
Tags:
Novartis, ONYX Pharmaceuticals, M&A
Why Is Novartis in Trouble in Japan?
Wall St. Cheat Sheet
Tue, 08/13/13 - 10:47 am
Tags:
Japan, Novartis, Diovan
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
Tags:
R&D, AstraZeneca, Bayer, Eli Lilly, Novartis, Pfizer, Regeneron, Roche, Shire, Takeda
Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
Seeking Alpha
Fri, 08/9/13 - 04:57 pm
Tags:
earnings, Regeneron, Eylea, Amgen, Novartis, Pfizer, Sanofi
Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Fri, 08/9/13 - 10:30 am
Tags:
wet age-related macular degeneration, diabetic macular edema, Lucentis, Novartis, Roche, Eylea, Regeneron, Optina, Ampio Pharmaceuticals
Generic Drugmakers Face An Increasingly Uncertain World: Moody's
Pharmalot
Thu, 08/8/13 - 08:33 am
Tags:
generics, Mylan, Novartis, Supreme Court, Teva, Actavis
Novartis drug shows no survival benefit in liver cancer
Chicago Tribune, IL
Wed, 08/7/13 - 09:15 am
Tags:
liver cancer, Novartis, Afinitor
Patient taking Novartis MS pill developed rare disease
Reuters
Tue, 07/30/13 - 01:20 pm
Tags:
Novartis, MS, multiple sclerosis, Gilenya
More Bad News For Novartis Blood Pressure Drug
Forbes
Tue, 07/30/13 - 01:12 pm
Tags:
Novartis, Diovan, antihypertensives
Europe backs new dual-action Novartis lung drug
Reuters
Fri, 07/26/13 - 11:29 am
Tags:
Europe, Novartis, Ultibro Breezhaler
A Look at Four Major Players in Multiple Sclerosis Treatments
Motley Fool
Wed, 07/24/13 - 12:55 pm
Tags:
MS, multiple sclerosis, XenoPort, BiogenIdec, Novartis, Alkermes, Tecfidera, Gilenya, ALKS 7106
A Biotech Betting Everything on a Single Drug
Motley Fool
Wed, 07/24/13 - 11:46 am
Tags:
Questcor, Pfizer, Biogen Idec, Acthar, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.